CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Planned sale President and CEO sold 15,000 shares at $12.68 ($190,200)
- 4 Planned sale President and CEO sold 10,000 shares at $12.68 ($126,800)
- 4 Open-market sale Chief Financial Officer sold 4,222 shares at an average $11.49 ($48,507)
- 4 Grant or award Director acquired 12,620 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 2,845 shares at $11.48 ($32,661)
- 4 Grant or award Director acquired 12,620 shares (grant or award)
- 4 Grant or award Director acquired 12,620 shares (grant or award)
- 4 Open-market sale General Counsel sold 3,776 shares at $11.48 ($43,348)
- 4 Open-market sale President and CEO sold 6,533 shares at an average $11.48 ($75,009)
- 4 Grant or award Director acquired 12,620 shares (grant or award)
- 4 Grant or award Director acquired 12,620 shares (grant or award)
- 4 Grant or award Director acquired 12,620 shares (grant or award)
- 4 Grant or award Director acquired 12,620 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 1,264 shares at $11.03 ($13,942)
- 4 Open-market sale Chief Commercial Officer sold 1,206 shares at $11.03 ($13,302)
- 4 Open-market sale General Counsel sold 1,264 shares at $11.03 ($13,942)
- 4 Open-market sale President and CEO sold 2,895 shares at $11.03 ($31,932)
- 4 Open-market sale President and CEO sold 3,631 shares at $5.93 ($21,532)
- 4 Open-market sale General Counsel sold 1,069 shares at $5.93 ($6,339)
- 4 Open-market sale Chief Commercial Officer sold 1,055 shares at $5.93 ($6,256)
Page 6 of 12 · 229 filings